Processa Pharmaceuticals, Inc. Common (PCSA) Stock Price, Quote & AI Analysis
Live PCSA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Processa Pharmaceuticals, Inc. Common.
TradeVae provides AI-driven analysis and real-time market intelligence for Processa Pharmaceuticals, Inc. Common (PCSA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Processa Pharmaceuticals, Inc. Common's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Processa Pharmaceuticals, Inc. Common Overview
Company information
Company Overview
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Processa Pharmaceuticals, Inc. Common Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...